Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC) Meeting Abstract
| Authors: | Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P.; Horwitz, S.; Kumar, A.; Matasar, M.; Moskowitz, A.; Moskowitz, C.; Noy, A.; Palomba, M. L.; Portlock, C.; Straus, D.; Zelenetz, A.; Seshan, V.; Younes, A. |
| Abstract Title: | Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC) |
| Meeting Title: | 5th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 17 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Sep 13-16 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-09-01 |
| Start Page: | S375 |
| End Page: | S376 |
| Language: | English |
| ACCESSION: | 124936158 |
| DOI: | 10.1016/j.clml.2017.07.217 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: NHL-195 -- Accession Number: 124936158 -- Entry Date: In Process -- Revision Date: 20170904 -- Publication Type: Article -- Supplement Title: Sep2017 Supplement 2 -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20 |
Altmetric
Citation Impact
BMJ Impact Analytics
